SEC 13F Intelligence

D. E. Shaw & Co., Inc. / AMGN

D. E. Shaw & Co., Inc.’s Amgen Inc Position

Does D. E. Shaw & Co., Inc. own Amgen Inc (AMGN)? Yes — 178.0K shares worth $63M (+0.04% of its 13F portfolio) as of Q1 2026, up from 29.0K shares the prior filed quarter.

Position Value
$63M
Q1 2026
Shares
178.0K
% of Portfolio
+0.04%
Quarters Held
30
currently held

Position History AMGN

Reported value by quarter
Q4 ’18: $100MQ4 ’18Q1 ’19: $308MQ2 ’19: $244MQ3 ’19: $241MQ4 ’19: $63MQ4 ’19Q1 ’20: $189MQ2 ’20: $52MQ3 ’20: $25MQ4 ’20: $40MQ4 ’20Q1 ’21: $209MQ2 ’21: $279MQ3 ’21: $267MQ4 ’21: $332MQ4 ’21Q1 ’22: $225MQ2 ’22: $236MQ3 ’22: $181MQ4 ’22: $328MQ4 ’22Q1 ’23: $77MQ2 ’23: $173MQ3 ’23: $219MQ4 ’23: $160MQ4 ’23Q1 ’24: $118MQ2 ’24: $96MQ3 ’24: $54MQ4 ’24: $515MQ4 ’24Q1 ’25: $393MQ2 ’25: $175MQ3 ’25: $36MQ4 ’25: $9MQ4 ’25Q1 ’26: $63Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026178.0K$63M+0.04%
Q4 202529.0K$9M+0.01%
Q3 2025128.9K$36M+0.02%
Q2 2025625.1K$175M+0.12%
Q1 20251.26M$393M+0.35%
Q4 20241.97M$515M+0.38%
Q3 2024166.4K$54M+0.05%
Q2 2024306.7K$96M+0.09%
Q1 2024413.7K$118M+0.10%
Q4 2023555.8K$160M+0.14%
Q3 2023816.6K$219M+0.23%
Q2 2023780.6K$173M+0.18%
Q1 2023318.2K$77M+0.08%
Q4 20221.25M$328M+0.36%
Q3 2022803.1K$181M+0.22%
Q2 2022971.1K$236M+0.28%
Q1 2022931.1K$225M+0.21%
Q4 20211.47M$332M+0.28%
Q3 20211.26M$267M+0.24%
Q2 20211.15M$279M+0.24%
Q1 2021838.0K$209M+0.20%
Q4 2020172.9K$40M+0.04%
Q3 202096.6K$25M+0.03%
Q2 2020220.7K$52M+0.06%
Q1 2020932.0K$189M+0.29%
Q4 2019262.2K$63M+0.07%
Q3 20191.24M$241M+0.30%
Q2 20191.32M$244M+0.30%
Q1 20191.62M$308M+0.40%
Q4 2018512.5K$100M+0.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See D. E. Shaw & Co., Inc.’s full portfolio or all institutional holders of AMGN.